High-flow nasal cannula versus noninvasive ventilation after extubation in people with systolic heart failure
Official title: A Prospective Randomized Controlled Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
Run by Yale University · NCT06671015 · Data updated 2026-11-12
This pilot will test whether high-flow nasal cannula or noninvasive ventilation after extubation better prevents reintubation in adults with systolic heart failure who were on a ventilator.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Yale University Academic / other |
| Locations | 1 site (New Haven, Connecticut) |
| Status | Recruiting |
| Started | October 4, 2025 |
| Main results expected | January 2027 |
| Study ends | February 2027 |
| Registry record updated | May 28, 2026 |
| Trial ID | NCT06671015 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with systolic left ventricular dysfunction (ejection fraction ≤40%) who have been mechanically ventilated for more than 24 hours and are ready for planned extubation in the CICU or MICU are ideal candidates.
✕Probably not a fit
Patients with active COPD exacerbation or chronic hypercapnia, pre-existing NIV prescriptions, tracheostomies, do-not-resuscitate orders, agitation or inability to cooperate, prisoners, or those who self-extubate are excluded and unlikely to benefit from the study interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an open-label, randomized 1:1 pilot trial at Yale New Haven Hospital enrolling adults with systolic heart failure (ejection fraction ≤40%) who have been mechanically ventilated for more than 24 hours and are ready for planned extubation. Participants are randomized to extubation supported by either high-flow nasal cannula (HFNC) or noninvasive ventilation (NIV) using the Airvo 3 device. The primary outcomes are rates of reintubation and post-extubation respiratory failure, with reintubation decisions made by the attending physician. Results will inform the design and power calculations for a larger randomized controlled trial.
Why it matters
Potential benefit: If successful, this approach could reduce reintubation rates and respiratory complications after extubation in people with systolic heart failure.
How similar studies have gone: Prior ICU trials comparing HFNC and NIV in mixed patient groups have shown mixed but often encouraging results, but randomized data specifically in high-risk systolic heart failure patients are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient is a male or non-pregnant female greater than or equal to 18 years of age * The patient is ventilated for greater than 24 hours * The patient has a systolic left ventricular dysfunction defined as an ejection fraction less than or equal to 40% * The patient, or legally authorized representative, has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent, approved by the appropriate Institutional Review Board (IRB) or Ethics Committee (EC). Exclusion Criteria: * Patients actively being treated for a COPD exacerbation or known hypercapnia (PaCO2\>45) on last Arterial Blood Gas (ABG) * Patients agitated or uncooperative state * Patients with do-not-resuscitate orders * Patients presenting with tracheostomies or anatomical abnormalities interfering with mask fit * Patients are prisoners * Patient self-extubates * Patients with pre-existing NIV prescription (e.g., obstructive sleep apnea, neuromuscular disorders, advanced COPD)
Where it's running
-
Yale New Haven Hospital (CICU or MICU)
New Haven, Connecticut, United States Recruiting
Study contacts
- Principal investigator: Elliott Miller, MD, MS — Yale University
- Study coordinator: Elliott Miller, MD, MS
- Email: elliott.miller@yale.edu
- Phone: 203-737-6390
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HFNC During Bronchoscopy for Respiratory Failure
This study tests whether using high-flow nasal oxygen during fiber-optic bronchoscopy is safe and helpful for patients with respiratory failure.
-
Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study
This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.
-
Epidural spinal cord stimulation to help breathing after cervical spinal cord injury
This trial tests whether adding epidural spinal cord stimulation to standard care can improve breathing in adults with cervical spinal cord injury and respiratory failure.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Ciprofol versus propofol for sedating adult ICU patients on noninvasive respiratory support
See if ciprofol works better than propofol for sedating adults in the ICU who are receiving noninvasive ventilation, high-flow nasal cannula, or oxygen therapy.
-
Using EEG to monitor sleep quality in ICU patients with respiratory failure
We will test whether continuous EEG monitoring can better track sleep quality than nurse observations in conscious adults hospitalized in the ICU for acute respiratory failure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.